Trial news

We have now reached 277 participants randomised and 375 participants screened meaning we have recruited 74% of our goal for analysis stage 1 (375)!

Asian MS: OCTOPUS and diversity in clinical trials webinar

We have now reached 245 participants randomised and 303 participants screened meaning we have recruited 65% of our goal for analysis stage 1 (375)!

So far:

• 13 hospital sites are open and actively contacting potential participants.
• 413 potential participants have been through telephone screening by their chosen site.
• 296 have attended their chosen hospital site for further screening and to give consent.
• 241 participants have entered the Octopus trial and started trial treatment.
• Another 134 participants will start treatment on the Octopus trial by December 2024 – to reach the goal of 375 participants in this first stage of the trial.